Vagotonic Effect of Remifentanil in Reference to Sympathetic or Parasympathetic Predominance of Autonomic Nervous System.
Phase of Trial: Phase IV
Latest Information Update: 07 Oct 2015
At a glance
- Drugs Remifentanil (Primary)
- Indications Intraoperative pain
- Focus Pharmacodynamics
- 07 Oct 2015 Last Checked against ClinicalTrials.gov record.
- 01 Oct 2015 The time frame for primary end point will be analysed now before and now injection instead of up to 2 years as reported by ClinicalTrials.gov record.
- 03 Aug 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.